These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17027885)

  • 1. Peripheral blood gene expression signature mirrors central nervous system disease: the model of multiple sclerosis.
    Achiron A; Gurevich M
    Autoimmun Rev; 2006 Oct; 5(8):517-22. PubMed ID: 17027885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity.
    Achiron A; Gurevich M; Friedman N; Kaminski N; Mandel M
    Ann Neurol; 2004 Mar; 55(3):410-7. PubMed ID: 14991819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse.
    Achiron A; Feldman A; Mandel M; Gurevich M
    Ann N Y Acad Sci; 2007 Jun; 1107():155-67. PubMed ID: 17804543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment.
    Lindberg RL; Kappos L
    Expert Rev Mol Diagn; 2006 Nov; 6(6):843-55. PubMed ID: 17140371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease.
    Bomprezzi R; Ringnér M; Kim S; Bittner ML; Khan J; Chen Y; Elkahloun A; Yu A; Bielekova B; Meltzer PS; Martin R; McFarland HF; Trent JM
    Hum Mol Genet; 2003 Sep; 12(17):2191-9. PubMed ID: 12915464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosis.
    Achiron A; Gurevich M; Snir Y; Segal E; Mandel M
    Clin Exp Immunol; 2007 Aug; 149(2):235-42. PubMed ID: 17488294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy.
    Singh MK; Scott TF; LaFramboise WA; Hu FZ; Post JC; Ehrlich GD
    J Neurol Sci; 2007 Jul; 258(1-2):52-9. PubMed ID: 17467740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy monitoring in patients with multiple sclerosis based on transcriptomic analysis].
    Zettl UK; Goertsches RH
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S64-8. PubMed ID: 19685398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Deficient mRNA expression of specific protein 3 gene in peripheral blood mononuclear cells from patients with multiple sclerosis].
    Lin AY; Yang QD; Murong SX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):187-9. PubMed ID: 18393243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in genetic analysis of multiple sclerosis: genetic associations and therapeutic implications.
    Niino M; Fukazawa T; Kikuchi S; Sasaki H
    Expert Rev Neurother; 2007 Sep; 7(9):1175-88. PubMed ID: 17868016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-expression profiling of peripheral blood mononuclear cells in sepsis.
    Tang BM; McLean AS; Dawes IW; Huang SJ; Lin RC
    Crit Care Med; 2009 Mar; 37(3):882-8. PubMed ID: 19237892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-based blood transcriptomes and interactomes in multiple sclerosis: involvement of SP1 dependent gene transcription.
    Menon R; Di Dario M; Cordiglieri C; Musio S; La Mantia L; Milanese C; Di Stefano AL; Crabbio M; Franciotta D; Bergamaschi R; Pedotti R; Medico E; Farina C
    J Autoimmun; 2012 May; 38(2-3):J144-55. PubMed ID: 22119415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomics in multiple sclerosis--current state and future directions.
    Comabella M; Martin R
    J Neuroimmunol; 2007 Jul; 187(1-2):1-8. PubMed ID: 17400297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling.
    Lemmer ER; Friedman SL; Llovet JM
    Semin Liver Dis; 2006 Nov; 26(4):373-84. PubMed ID: 17051451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future applications of transcriptomics for discovery in CNS disease and injury.
    Munro KM; Perreau VM
    Neurosignals; 2009; 17(4):311-27. PubMed ID: 19816067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients.
    Weinstock-Guttman B; Bhasi K; Badgett D; Tamaño-Blanco M; Minhas M; Feichter J; Patrick K; Munschauer F; Bakshi R; Ramanathan M
    J Neuroimmunol; 2008 Dec; 205(1-2):113-25. PubMed ID: 18950872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel interferon-beta-induced gene expression in peripheral blood cells.
    Rani MR; Shrock J; Appachi S; Rudick RA; Williams BR; Ransohoff RM
    J Leukoc Biol; 2007 Nov; 82(5):1353-60. PubMed ID: 17709400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translation towards personalized medicine in Multiple Sclerosis.
    Miller A; Avidan N; Tzunz-Henig N; Glass-Marmor L; Lejbkowicz I; Pinter RY; Paperna T
    J Neurol Sci; 2008 Nov; 274(1-2):68-75. PubMed ID: 18789804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular biomarkers for prediction of multiple sclerosis relapse].
    Satoh J
    Nihon Rinsho; 2008 Jun; 66(6):1103-11. PubMed ID: 18540355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-expression profiles of peripheral blood mononuclear cell subpopulations in acute graft-vs-host disease following cord blood transplantation.
    Takahashi N; Sato N; Takahashi S; Tojo A
    Exp Hematol; 2008 Dec; 36(12):1760-1770. PubMed ID: 18814951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.